The epidemic emergence of HIV: what novel enabling factors were involved? by Sousa, Joao Dinis et al.
Perspective
For reprint orders, please contact: reprints@futuremedicine.com
The epidemic emergence of HIV: what novel
enabling factors were involved?
Joa˜o Dinis Sousa*,1,2, Viktor Mu¨ller3,4 & Anne-Mieke Vandamme1,2
1Department of Microbiology & Immunology, Rega Institute for Medical Research, Clinical & Epidemiological Virology, KU Leuven -
University of Leuven, B-3000, Leuven, Belgium
2Center for Global Health & Tropical Medicine, Unidade de Microbiologia Me´dica, Instituto de Higiene e Medicina Tropical,
Universidade Nova de Lisboa, Lisbon, Portugal
3Institute of Biology, Eo¨tvo¨s Lora´nd University, Budapest, Hungary
4Evolutionary Systems Research Group, MTA Centre for Ecological Research, Tihany, Hungary
* Author for correspondence: joao.sousa@kuleuven.be
Humans acquired retroviruses from simians, mainly through bushmeat handling. All epidemically suc-
cessful HIV groups started to spread in early 20th century, contrasting with the antiquity of T-cell lym-
photropic viruses, implying that novel enabling factors were involved in HIV emergence. Here we review
the Parenteral Serial Transmission and the Enhanced Heterosexual Transmission hypotheses for the adap-
tation and early spread of HIV. Epidemic start roughly coincides in time with peak genital ulcer disease
in cities, suggesting a major role for sexual transmission. Only ill-adapted and rare HIV groups emerged
after approximately 1950, when injections and transfusions attained their maximal levels, suggesting that
if parenteral serial transmission was necessary for HIV adaptation, it had to be complemented by sexual
transmission for HIV to reach epidemic potential.
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Both human immunodeficiency virus types (HIV-1 &HIV-2) have been acquired by humans from nonhuman pri-
mates infected with simian immunodeficiency virus (SIV). HIV-1 comprises four known groups, each demonstrably
derived from an independent simian-to-human transmission [1]. The pandemic group M (HIV-1-M), and the rare
group N (HIV-1-N) originated from SIV infecting central chimpanzees (Pan troglodytes troglodytes; SIVcpz) living
in southeast and south-central Cameroon, respectively [1–3]. HIV-1 group O (HIV-1-O, which infects <20,000
people in Central Africa) and the rare group P (HIV-1-P) originated from SIVgor, endemic in western lowland
gorillas (Gorilla gorilla gorilla) [4,5]. HIV-2 is divided into nine known groups (A–I), all independent crossovers
from SIVsmm, infecting West African sooty mangabeys (Cercocebus atys atys) [6–9]. Of these, only groups A and B
have spread widely, probably infecting together more than one million people [10]; HIV-2 groups D and F were
found in two individuals each [6,8,9]; the remaining HIV-2 groups (C, E, G–I) were identified in just one person
each [6,7], and might therefore not deserve the classification of a group.
SIV infection is reportedly present in 45 of the 73 known species of African primates, and SIV-carrying primate
species reach most areas of sub-Saharan Africa [11]. However, it is not clear why only SIVcpz, SIVgor and SIVsmm
generated epidemics in humans. For a successful cross-species transmission, SIV needs to be able to use the
appropriate receptors and co-receptors on the cells of the new host, and to adapt to counteract host-specific
restriction factors, such as APOBEC3G, TRIM5α, or tetherin. Variation might exist among SIVs in their degree
of preadaptation to any of these human biological restrictions [1,3,12], but data to support this are currently lacking
for most SIV variants.
It is generally accepted that humans acquired these viruses from simians through bushmeat handling [1,7]. While
the phylogenetic structure of HIV groups and their relation to SIVs are now well established, the processes that led
to their epidemic emergence are still debated. In the absence of solid evidence of causation, this debate is largely
based on correlation analyses. Here we review the state of this debate, including our own contribution to it, and
attempt to outline the likely future evolution in this field. We will focus on the three SIVs that are linked to HIV
epidemics.
Staging the transformation of SIV to epidemic HIV & evidence of concomitant adaptation
According toWolfe et al. (2007) [13], an animal pathogen can be transformed into a specialized pathogen of humans
through five evolutionary stages, the more advanced of which require adaptation. In Stage 1, the pathogen is still
present in animals only. In Stage 2, it is able to infect humans, but there is no human-to-human transmission
(e.g., rabies). In Stage 3, limited transmission between humans occurs, but it is not sustained, the outbreaks die
out (e.g., Ebola). In Stage 4, transmission between humans is important, but many new imports from animals
(‘sylvatic transmission’) are constantly occurring (e.g., dengue). In Stage 5, the pathogen is exclusively human and
the epidemic is self-sustained (e.g., epidemic HIV, Plasmodium falciparum) [13].
Two large-scale studies found 8–17% SIV seroreactivity in modern HIV negative Central Africans exposed to
bushmeat, its frequency correlated with exposure. No viruses could be isolated or sequenced [14,15]. Thus, human
SIV infections are frequent, but mostly unproductive and not transmitted further, which classifies them mostly as
Stage 2 infections. The rare HIV-2 groups found in just one patient each (C, E, G, H, I) may also be examples
of Stage 2; there is currently no evidence for higher stages. The rare HIV groups that have demonstrably spread
among humans (HIV-1-N, HIV-1-P, HIV-2-D and HIV-2-F) may represent short-lived outbreaks (Stage 3), with
some potential to transition to higher stages [1,16–19].
The rare forms of HIV-2, one of the two known HIV-1-P isolates, and also the epidemic HIV-2-B, have the
amino acid methionine in the Gag30 position, like SIVcpz, SIVgor and SIVsmm. In contrast, HIV-1-M, HIV-1-O,
HIV-1-N and HIV-2-A have all evolved an arginine at this position, and careful experiments demonstrated that
this convergent change is an adaptation to the human host [1,16]. The four epidemic groups of HIV (HIV-1-M,
HIV-1-O, HIV-2-A, HIV-2-B) each derive from a single simian-to-human transfer and now infect between tens
of thousands to millions of people, so they have all clearly undergone the transitions to Stage 5. Several studies
have demonstrated various additional adaptations as compared with the rare groups: adaptations to human host
restriction factors, receptors and human leucocyte antigens (HLA). HIV-1-M, HIV-1-O and HIV-2 have all
evolved the capacity to antagonize human tetherin, controlled by genomic sites in Vpu, Nef and Env, respectively,
while their ancestors (SIVcpz, SIVgor and SIVsmm) all use Nef to combat simian tetherin (HIV-1-O evolved this
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function through a site in Nef different from the site used by SIVgor) [1,17,18]. There are other HIV adaptations,
such as downregulation of human CD4, HLA-A, HLA-B and HLA-C [1,19].
The timing of the HIV groups & the evidence for novel factors enabling epidemic emergence
The timings of human T-cell lymphotropic viruses (HTLV), the first group of human retroviruses discovered,
contrast with those of HIVs. The estimated time of the most recent common ancestor (tMRCA) of the different
HTLV type 1 (HTLV-1) subtypes span between approximately 5000 and 50,000 years ago [20,21], while HTLV-2 has
crossed into humans between 60,000 and 400,000 years ago [20–22]. The slave trade of the centuries preceding the
20th, exported some HTLV-1 subtypes [22] to the Americas, confirming their ancient origin. Simian foamy virus,
the only other simian retrovirus infecting humans through bushmeat handling, infects many Central Africans, but
there is no evidence of ongoing transmission between humans [23] (i.e., simian foamy virus is stuck in Stage 2).
In contrast to HTLV, all known HIV groups emerged recently and the epidemic groups did so almost simulta-
neously in the first half of the 20th century. This was shown by phylogenetic analyses that were used to estimate
the tMRCA of the main epidemic strains. For HIV-1-M, estimates of tMRCA fall in the period 1908–1930 [24–27];
the most recent analyses calculated 1908 (1884–1924) [26] and 1920 (1909–1930) [27]. A similar time-frame was
estimated for HIV-1-O at 1920 (1890–1940) [28], and the tMRCAs of HIV-2 groups A and B were estimated at
1938 (1928–1947) [29] and 1945 (1931–1959) [30], respectively. The rare HIV groups seem to be younger. For
HIV-1-N, a tMRCA of 1963 (1948–1977) was estimated [31]. No tMRCA calculation was performed for HIV-1-P,
since only two strains are known, but their split is approximately as deep as the HIV-1-N MRCA [4]. Similarly, the
split between the two known lineages of HIV-2-F appears to be more recent than both the tMRCAs of HIV-2-A
and HIV-2-B [9]. There is currently no evidence supporting the presence of HIV outside Africa prior to the 1960s.
All HIV viruses sequenced from African-Americans to date belong to one of the known HIV groups, the origin of
which appears to be after late 19th century, and their spread out of Africa has been dated phylogenetically to after
the 1960s.
Several lines of evidence suggest that opportunities for simian–human cross-species transmission of SIV have long
been present in Africa. First, an analysis of SIV sequences of monkeys inhabiting the Bioko island, which became
isolated from mainland Africa 10,000–12,000 years ago, permitted to calibrate the entire SIV phylogenetic tree,
suggesting an estimate for the age of this virus group of at least 77,000 (33,000–133,000) years [32], consistent with
an ancient presence of SIV on the African continent. Second, the large-scale serological studies of Central Africans
exposed to bushmeat [14,15], suggest SIV infections are common and related to bushmeat handling. Therefore, the
epidemic emergence of HIV (i.e., the transition of HIV to Stage 5) was most likely helped/enabled by novel factors
becoming effective after late 19th century. This timing consideration led to several hypotheses of enabling factors,
including urbanization, sexually transmitted diseases (STD), unsafe injections, and transfusions [33–43].
Potential enabling factors
The origin of the HIV epidemics and the HIV-1 group M pandemic raises at least three different ‘how’ questions:
how did the original jump of SIV to humans take place?; how did adventitious SIVs turn into HIVs acquiring
epidemic or pandemic potential (i.e., Stage 5 potential)?; and, how are the current epidemics and pandemic
progressing (which factors fuel spread)? With regard to the first question, the original interspecies jump was a
result of bushmeat hunting, butchering or handling, as is widely recognized [1,2,35–43], and we argued above that
this had been happening for millennia without giving rise to HIV. With regard to the third question, the current
epidemics of HIV in African populations are mostly fueled by heterosexual transmission [44,45]. So, the first and
third questions are not contentious. The second question is more difficult to investigate empirically. It raises also
the question which process permitted adaptation to evolve.
Emergence and early spread of HIV may have been enabled by several factors. Some of them may have favored
more interspecies transmissions, some may have favored incipient adaptation, and some may have helped human-
to-human transmission even of ill-adapted strains. None of these enabling factors are mutually exclusive, some of
them probably acted in concert and some of them had long been present in tropical Africa. However, to explain
the observed phylogenetic pattern, a particular combination of such factors or some specific factors must have been
novel, not present before the late 19th century, and some of the novel factors may have been indispensable for the
transition.
Already in prehistoric times, human bushmeat hunting of primates likely caused numerous Stage 2 (dead-end)
human infections with SIV, and possibly some short-lived Stage 3 outbreaks. Organized colonialism started in inner
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Central and West Africa around 1885. It triggered several changes potentially relevant for HIV emergence: possible
increase in primate hunting, urbanization and related social changes [26,46], medical injections, vaccinations, and
transfusions [34–39], and spread of sexually transmitted infections (STI) and related diseases (STD) [40,41]. Some
of these factors may have increased human exposure to SIV, while others may have increased either parenteral or
sexual transmission potential – which may have been important for adaptation and early spread of a still ill-adapted
zoonotic virus. These processes may have generated more common Stage 3 outbreaks.
Adaptation to host restriction factors may have been facilitated by biological processes that are not novel, such
as the high viremia during acute infection [35], a high transmitted viral diversity upon cross-species transfer [47–49],
or synergistic interactions with other pathogens [50]. Even within a single SIV species some strains may be better
pre-adapted to sustain infection in humans than others, as was demonstrated for SIVcpz [3]. Host susceptibility
factors may also have played a role: lack of male circumcision [43], cytokine profile, or HLA haplotype [51].
Among the synergistic interactions, several pathogens are known to increase HIV viral load [52]. In addition,
STD-causing pathogens faciliate HIV transmission by increasing inflammation and HIV genital viral load, and
additional mechanisms [40,53,54].
Here we concisely review these factors and their possible contribution. We pay special attention to the factors
that could have enhanced either sexual or parenteral transmission for the following reasons. First, they might have
helped adaptation [35,36]. Second, they either started or greatly intensified after organized colonialism began (as we
will discuss), thus meeting the criterion of novelty. And third, most of the published hypotheses of HIV origins has
focused on them.
Viral diversity & adaptation to a new host species
Pathogenic and adapted SIVmac, SIVstm and SIVmne emerged in captive Asianmacaques in the 1970s, and resulted
from several accidental cross-species transfers of SIVsmm from sootymangabeys in captivity. A phylogenetic analysis
suggests that highly invasive kuru experiments (likely to transmit high viral diversity) caused most of these cross-
species transfers and allowed further serial passage in the new host species [55]. Similarly, in experimental transfer of
SIVsmm to rhesus macaques, the initial transmitted diversity greatly contributed to adaptation to the new host [47].
Thus, several experiments suggest that upon cross-species transfer, viral diversity matters to facilitate adaptation.
After more than 100 chimpanzees were experimentally infected with HIV-1, only the strain HIV-1NC readapted
sufficiently to the former host and causes AIDS. HIV-1NC, a recombinant between HIV-1LAV1b and HIV-1SF2,
evolved in one of the few animals that were superinfected with multiple HIV-1 strains. After evolving in one host,
HIV-1NC promptly caused CD4 T-cell decline when transmitted to other chimpanzees [48,49]. Thus, superinfection
and recombination may be important for adaptation after a cross-species transfer.
Drawing a parallel with HIV origins, these studies could suggest that, among SIV-infected humans, a minority
may have received larger blood inoculums (e.g., a deep wound), or may have been multiply infected in a short
period (e.g., after butchering two or more primates), thereby acquiring a higher diversity of SIV, potentiating partial
adaptation. This might have been a template for Stage 3 human HIV infections even in ancient times. However,
such events have been occurring for millennia, and Stage 5 HIV did not emerge. Thus, further adaptation than that
potentiated by any of these processes was probably needed to generate several long-lasting HIV epidemic groups
nearly simultaneously in the 20th century.
Large population agglomerations & firearms were not novel factors
Firearms were smuggled in great numbers to southeast Cameroon and nearby areas in early 20th century, peaking
in the period 1900–1907 [41,56]. They facilitate ape hunting, and there are reports that the latter was common
in the region by that time [41]. However, firearm exports from Europe to Africa had been massive for centuries,
including to the inner Congo basin [57,58], so they were not a novel factor in early 20th century.
Well before colonialism, several towns/agglomerations existed in forested Central Africa with populations up
to approximately 10,000, comparable to the colonial cities of the period 1910–1925 [58]. Thus, urbanization, in
the strict sense of larger agglomerations, was not a novel factor. However, colonial urbanization may have been
favorable to HIV emergence because of the associated profound societal changes [38,40].
The serial transmission hypothesis of adaptation to a new host species
HIV adaptation to humans was necessary for epidemic emergence. Nonadapted adventitious SIV is unlikely to
sustain detectable viral load after acute infection [14,15] and potential human-to-human transmission is therefore
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Figure 1. The process of simian immunodeficiency virus adaptation by serial transmission.
In a typical cross-species transmission of SIV the virus is suppressed after acute infection initially (A); with serial
transmission through sequential acute-stage infections, the virus gradually adapts to the new host and acquires the
ability to sustain substantial viral load past acute infection (B). The time course of the viral load in the individual
infections is shown in red (X-axis is time since infection, Y-axis is viral load).
SIV: Simian immunodeficiency virus.
For color figures please see www.futuremedicine.com/doi/full/10.2217/fvl-2017-0042
restricted to acute infection. Marx et al. (2001) [35] proposed that SIV might have adapted to humans, becoming
HIV, by accumulation of favorable mutations during a few serial transmissions among humans, transmitted in
the acute stage of the infection. The concept of adaptation of a virus to a new host species by serial transmission
is supported by experimental serial passage of SIV among macaques [35,55] and of H5N1 among ferrets [59]. The
process is illustrated in Figure 1.
Marx et al. (2001) proposed that the arrival of medical injections to Africa following European colonization (with
significant inland penetration only after the Berlin Conference in 1885) provided themeans for serial transmission of
SIV to occur, since sterilization of equipment was often absent [35]. In this parenteral serial transmission hypothesis,
unsterile injections only provide the initial adaptive event; it does not imply that subsequent transmission is mainly
parenteral.
Injections were already common in early 20th century Central and West Africa [34,36–38,41], particularly to
treat syphilis, yaws and trypanosomiasis, and to vaccinate against smallpox, and they could have enabled serial
transmission. Moreover, many were intravenous, posing a higher risk of SIV/HIV transmission [44,45] than the
mostly intramuscular injections performed after 1950.
Gisselquist (2003) emphasized that campaigns against trypanosomiasis in Cameroon, in which many rural
patients were treated together by mobile teams, could have caused adaptation of HIV-1-M and HIV-1-O [36]. Our
own review of archival and colonial medical data for Cameroon show that trypanosomiasis treatments peaked in
1924–1928 (thus roughly coinciding with the tMRCAs) and then declined, becoming negligible in the 1950s [41].
Schneider and Drucker (2006) suggested a possible role of blood transfusions in the origin of HIV [39]. The
probability of HIV-1 transmission per transfusion is >90%. However, transfusion services or programs seem to
have been established in the Belgian Congo (now Democratic Republic of Congo) and Senegal in the 1940s, and
reached many more African countries only in the next decade. There are only isolated reports of transfusions from
the 1920s [39]. However, in a few desperate trypanosomiasis cases, blood taken from convalescent patients was
sometimes injected [38].
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Other parenteral hypotheses & evaluation of related risk factors
The massive parenteral transmission hypothesis
Pe´pin and Labbe´ (2008) and Pe´pin (2011) proposed that unsafe injections used mainly against syphilis, yaws, and
trypanosomiasis might have massively transmitted SIV/HIV in rural areas, generating thousands of infections, with
sexual transmission taking over only later on [37,38]. We call this the massive parenteral transmission hypothesis.
HIV epidemic expansion by the parenteral route has only been reported in groups of intravenous drug users
(IVDU), and in some hospital outbreaks, characterized by extremely high levels of needle sharing/reuse. Western
IVDUs inject themselves 300–1800 times a year and rapid HIV-1 spread happened more commonly in the 1980s,
when the number of unsafe needle shares per IVDU per year was 60–245 [41]. After needle exchange programs and
other harm reduction interventions reduced the sharing frequency to <30 per IVDU per year, HIV-1 declined or
became stagnant in this risk group (i.e., with a basic reproductive number, R0 <1; R0 measures the number of
new infections caused by a single infected during his/her infectious period in a fully susceptible population; an
epidemic can only be started if R0 >1). In contrast, the parenterally more transmissible hepatitis C virus (HCV)
has remained at high prevalence (for details, see our review [41]). Similarly, in the rare documented HIV-1 hospital
outbreaks, needles were reused in patients with annual frequencies estimated at 40–200 per patient, with riskier
procedures also present [41,44,60].
Colonial medical articles reveal a far lower injection load in Central African rural populations in early 20th
century. Each person was inoculated against smallpox once each 5–8 years. In 1922–1931 Cameroon, the average
number of injections per patient per year in the treatment of yaws and syphilis was in the range 1.0–1.9 (including
arsenicals, bismuthics and mercurials). In rural clinics, syphilis treatments could involve a few more, but normally
<4. Only in major cities, some specialized STD clinics administered >15 injections per syphilis patient, starting in
approximately 1930 [41,61]. New trypanosomiasis patients in the period 1925–1935 would receive 6–12 injections
in the first year, and normally no more than 15–24 spread over 2 or more years [41,62]. Moreover, only about half
of these injections were intravenously administered (e.g., tryparsamide, rather than the intramuscular atoxyl) [41,62].
We conclude that the early 20th century Central African rural injection campaigns had an overall injection
intensity one to two orders of magnitude lower than the intensity of needle sharing required for IVDU and
hospital outbreaks where HIV-1 demonstrably had R0 >1 [41]. Thus, they may have spread HCV extensively [63]
(as happened with antischistosomiasis campaigns in Egypt, which had similar injection intensity [64]), but this has
not been demonstrated for HIV-1.
Finally, under the massive parenteral transmission hypothesis, we would expect more successful epidemic HIV
groups to have arisen in the antibiotic era (post-1950), when injections (many unsterile) became more common,
but the opposite is observed. It is remarkable that even with unsafe injections peaking across Africa in the period
1960–2000 [35,65], coinciding with the epidemic spread of the virus across the continent,<3% of HIV-1 infections
in Africa have been estimated to have been acquired by unsafe injections [44,45]. This suggests that unsafe injections
alone are unlikely to boost HIV-1 R0 above 1. For all these reasons, we consider this hypothesis unlikely.
The parenteral outbreak hypothesis
However, although overall injection intensity was low in early 20th century, it could have been substantially higher
at selected locations and during short periods (i.e., concentrated in time and space). Thus, we could devise a
parenteral outbreak hypothesis by which, in a health facility with unusually high parenteral risks (as in modern
hospital outbreaks [41,44,60]) ill-adapted HIV suddenly spread to some dozens of people. By infecting multiple hosts,
the virus would have higher chances of acquiring favorable mutations and hence adapting, later being transmitted
mostly by sexual contact.
For example, in the Croix Rouge STD clinic of Leopoldville (established in 1929), syphilis patients received
15–24 injections per year in 1933–1940 [41,61]. In the same city in the 1920s, very sick trypanosomiasis patients
were segregated in a lazaret and received dozens of injections per year [66].
Patterns of needle & syringe sterilization
Autoclaves were already used in the Brazzaville hospital for Africans as early as 1908 [67], and sources suggest
their use in the main Gabonese medical centres as well [38]. In the Belgian Congo, a source mentions ‘disinfection
pavillions’, equipped with ‘disinfection machines’ (which could be autoclaves or dry heat devices) in 1929, in the
hospitals for Africans of Leopoldville (now Kinshasa) and Stanleyville [68] – suggesting that the same was probably
true for the other main cities. The Leopoldville Laboratory, to which the trypanosomiasis lazaret was attached, had
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a sterilization room with autoclaves by 1922 [66]. These reports suggest that most hospitals of the main colonial
cities had these devices in early 20th century. In minor clinics of the countryside, sterilization of syringes, needles
and lancets was done by boiling [41,69,70].
However, as reviewed by Pe´pin (2011) [38], full sterilization by boiling or autoclave was mostly performed on an
end-of-day basis; when there was a long queue of patients to inject in a single day, cleaning of equipment between
one injection and the next had to be done by fast procedures: rinsing the needles and syringes with water, phenylated
water, alcohol or ether, passing the needles by a flame or plunging them in burning alcohol (reviewed in [38,41]).
These fast procedures would not sterilize fully and, in addition, often they were missed altogether, particularly when
practiced by inexperienced and/or unscrupulous healthcare workers in rural campaigns [38,70]. Even in Leopoldville,
many injections were probably unsterile, particularly in the Croix Rouge clinic [38], and they may therefore have
transmitted HIV-1. Both clinical data and phylogenetic analyses suggest that unsafe injections amplified hepatitis
B virus (HBV) and HCV in colonial Leopoldville [38,71].
Substantial HIV transmission may have happened through these processes; however, some caveats need to be
kept in mind. First, an experiment revealed that a simple rinsing with water reduced the probability of retrieving
HIV-1 from syringes by 55–80% [72]. Thus, the 0.6–2.4% per-reuse probability of transmission of HIV-1 associated
with intravenous injections [60,73] could be greatly reduced by the fast procedures described above. Second, in some
settings, in addition to rinsing, needles were flushed with distilled water, forcing it through the needle gun, to expel
any traces of blood [74], a very simple and fast procedure that probably reduces the risk of HIV transmission even
more markedly. Third, meta-analyses of transmission probability after needlestick injuries give mean estimates of
0.75–1.8% for HCV, which is 2.5–6-times higher than the corresponding value for HIV-1 [44,75,76]. The impact
of this transmission route at population level is likely to have been substantially lower for HIV than for HCV, and
thus, phylogenetic evidence for HCV spread through needles is not necessarily applicable to HIV spread.
And fourth, the more organized rural injection campaigns against trypanosomiasis were expensive, had extensive
associated examinations andmobile laboratory work, and descriptionsmade by their organizers suggest that hygienic
standards were high [69,70,77]. For example, even in the early (less well organized) campaigns by Eugene Jamot in
Cameroon in the early 1920s, all material was boiled every day [69]. Between injections, most often only fast rinsing
procedures were performed. However, in a paper written in 1929 (when his campaigns were better funded and
organized), Jamot describes the sterilization rules as follows. All syringes and needles should be boiled every day and
additionally the (detachable) needles should be changed between injections [70]. This implies that each injection
was most probably performed with a boiled needle not used in another patient since the last boiling. In campaigns
against trypanosomiasis and yaws in Sierra Leone, in which several hundreds of patients were being injected in the
same place and day, the organizers claimed that ‘needles are boiled between every injection but syringes are only
sterilized initially and not again unless blood should enter from a vein’ [77]. This practice might indeed have been
possible, if the team had a stock of hundreds of detachable needles which, given their small size, could be boiled
together once a day and be each used in only one injection per day. Of course, there was a tendency to describe
ideal procedures and, in the real world, sterilization was probably missed in a substantial proportion of injections.
Jamot himself recognized his rules had not always been followed by his personnel [70].
The method above would be more likely used in facilities performing no more than dozens of injections per day,
since they would need a correspondingly low number of needles, at relatively insignificant extra cost. This was the
case of the Leopoldville lazaret for trypanosomiasis patients [66,68].
In high turnover facilities, the standards might have been lower [38]. Overall, it is likely that in many high turnover
situations only fast cleaning procedures were performed, and in many cases even these were missed. Still, it should
be kept in mind that the necessity of sterilization was well known in early 20th century colonial Africa, and rules
for it existed in most health facilities. Unfortunately, no data exist to quantify the proportion of instances where
injections were unsafe.
The enhanced heterosexual transmission hypothesis
The serial transmission hypothesis of adaptation (Figure 1) could also work with sexual transmission. As in the
parenteral version, the probability of such an event is higher if exposures are frequent and concentrated in time and
space, and if the associated transmission probabilities are higher. The average per-act transmission probability in
long series of sex acts is near 0.1%, while it is 0.6–2.4% per-reuse of intravenous unsterile needles [60,73]. This, and
the fact that sex was not a novel factor in Africa, suggest that baseline sexual transmission cannot have accounted
for the origin of HIV.
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However, the consideration of genital ulcer disease (GUD) changes this picture. GUD causes inflammation
and CCR5 expression in T cells in the donor, thus greatly increasing HIV replication in the genital area and
contributing to amplified HIV transmission. In a recipient partner, GUD provides a portal of entry and increases
the number of target cells available for HIV. Inflammation in the recipient broadens the range of HIV phenotypes
that can successfully establish infection [78]. Thus, GUD greatly contributes to successful transmission by enhancing
both HIV transmissibility in the infected and susceptibility in the exposed person [40], and treatment of GUD in
either or both is an accepted measure to prevent HIV transmission [51,79]. Genital ulcers also facilitate SIVmac239
acquisition in macaques and speed up its systemic proliferation [80].
HIV-1 transmissibility in sexual acts in which active genital ulcers are present has been estimated in the range
4–43% per sexual act [53,54]. Based on this, we hypothesized that GUD could have helped serial transmission and
initial spread of still ill-adapted zoonotic HIV [40].
Epidemiologists noted early that there is an epidemiological synergy between STD pathogens and HIV [50], and
also that amplified transmission of HIV, associated with factors such as STDs, GUDs, acute infection, lack of male
circumcision and others play a disproportionate role in the epidemic [51]. We used these concepts to get insight into
HIV origins and early spread.
Since GUD is linked to commercial sex work and thus usually flourishes in cities, we reviewed health reports
of several colonial cities, focusing particularly on colonial Leopoldville [40], the epicenter of HIV-1-M [27]. Our
review indicated that the main GUDs reported for colonial Leopoldville (syphilis, chancroid and lymphogranuloma
venereum) were highly epidemic there in 1911–1935 [40]. GUD incidence was probably on the rise already between
1898 and 1910, but colonial reports give insufficient information for this period [40]. Before 1898, Leopoldville was
only a small colonial station without railway and so GUD incidence was probably lower. Contacts with southeast
Cameroon only became important after 1899 [41]. After 1935, the incidence rates of all reported GUDs (i.e., based
on the new cases of primo-secondary syphilis, chancroid and lymphogranuloma venereum) dropped with the mass
treatments implemented. These used neoarsenobenzol, bismuthic salts, mercury salts and acriflavine aimed at the
whole city population from the early 1930s. Incidence rates declined further with the introduction of antibiotics
in 1947, becoming rare in the late 1950s [40]. Incidence of total syphilis had declined only moderately by the
1950s, but this is counting the very numerous detections of asymptomatic serological cases and tertiary cases [40,81].
Counting primary and secondary syphilis cases only (the stages with genital ulcers) the decline was by two orders
of magnitude, which is similar to the decline in chancroid and lymphogranuloma venereum. Thus, in the period
1899–1935, GUD incidence was the highest ever recorded for the city, and contacts with southeast Cameroon
were important. This period coincides with the tMRCA of HIV-1-M.
We built computer simulations to investigate the possibilities of initial spread of ill-adapted zoonotic HIV-1
(suppressed after acute infection), in Leopoldville in 1919, 1929 and 1958 [40]. The results showed that long
chains of transmission during acute infection were far more probable in 1919 and 1929 than in 1958, when
the population of the city had grown further, but GUD prevalence had declined. After testing many different
scenarios, with variations in the transmission, demographic and other parameters as sensitivity tests, high GUD
prevalence emerged as the strongest facilitating factor for initial HIV-1 spread [40]. We thus proposed the enhanced
heterosexual transmission hypothesis, which posits that each epidemic HIV strain emerged through the concerted
presence in time and space of co-factors helping heterosexual transmission, including the interdependent factors
GUD, sexual promiscuity and lack of male circumcision [40,41,43]. Enhanced heterosexual transmission is not a new
finding, it has extensively been discussed in the past to understand the current HIV pandemic [50,51,53,54]. Our
contribution was to apply it to understand the origin of HIV. This hypothesis does not exclude a contribution
of parenteral transmission during the initial serial transmission of HIV among humans or in the subsequent early
spread among humans [40,41], or any of the other enhancing factors described in a separate section above. The core
of this hypothesis is however that without GUD, HIV epidemics would not have taken off.
Critiques to the original ‘enhanced heterosexual transmission’ simulation model
Our 2010 model was criticized for using a 43% per-act transmissibility of HIV-1 with GUD involvement (versus
the baseline of 0.1%) [81]. However, we used 43% only when two concomitant co-factors, GUD in the female,
and lack of circumcision in the male were present (supported by Cameron et al. [53]). In all other GUD-related
situations, we used transmission probabilities in the range 4–7% (thus with risk ratios above the baseline ranging
from 40 to 70). Often, much lower GUD-related risk ratios (e.g., <10) are reported, but these studies asked
participants whether they had GUD at any time within a long period (e.g., the last 12 months), a procedure that
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strongly underestimates the per-act GUD effect in acts during which GUD is active (reviewed in [82,83]). Our
sensitivity analyses showed that even with all males circumcised (and thus GUD-related transmission probabilities
in the range 4–7%), GUD was crucial to maintain transmission chains of acute infection.
Giles-Vernick et al. (2013) [42] pointed out that Leopoldville’s prostitutes in early 20th century had a far lower
turnover than the 600 client encounters a year that we postulated in our main 2010 model (we used this value based
on modern surveys of sex worker behavior [84]). We agree to this, but we note that, in the sensitivity analyses of
our model, 600 encounters a year was the maximum (supported by [84]), the range tested included 150 encounters
a year, and the main results remained valid in this range [40]. In addition, they claim that Leopoldville’s prostitutes
had few well known partners with whom they shared food and dwelling (implying a low turnover) [42]. Again,
we agree this applied to most women who were labeled as either ‘prostitutes’ or ‘femmes libres’, by the colonial
administration, but this mild sexual promiscuity was captured in our model by the femmes libres category, which
were far more numerous than the commercial sex workers. For example, for 1929, our model assumed 6049
femmes libres (supported by colonial surveys) and only 106 commercial sex workers (only the latter having 150–600
encounters per year) [40].
Our inclusion in the model of high turnover commercial sex workers and their number was realistic: some
descriptions of 1930s’ Leopoldville suggest their presence in several quarters: many behaved as streetwalkers and
had sexual encounters with clients in the bush-covered areas separating the European and African quarters within
the city [85].
GUD as a novel factor in tropical rainforest societies
However, was GUD a novel factor in the relevant regions? Since Africa is now more afflicted by GUD than other
continents, this idea seems odd at first sight. In this section, we present evidence that GUDs were virtually absent
in most tropical rainforest areas of Central and West Africa (the primary habitat of chimpanzees, gorillas, and sooty
mangabeys [2,6,33,40,86–88]) before organized colonialism (post-1885) began.
With prevalence rates in the range 30–80% [89], herpes simplex virus type 2 (HSV-2) is nowadays a major
cause of GUD in Africa. Through genital ulcers, inflammation and interactions with HIV, HSV-2 infection in an
HIV-infected or exposed subject greatly enhances both HIV transmissibility and susceptibility, respectively [90,91].
However, its prevalence in 1959 was only 6% in rural Congo and 21% in Leopoldville (having tripled since then,
following the worldwide trend) [92]. Both the low prevalence and the high urban–rural difference seen in 1959
suggest that HSV-2 prevalence in rural Central Africa, in early 20th century was probably very low.
Several lines of evidence indicate that syphilis and chancroid (caused by the bacteria Treponema pallidum
pallidum and Haemophilus ducreyi, respectively) were either absent or rare in Central Africa’s rainforest before
colonial times. First, reviewers explicitly state the absence of syphilis [93,94]. Second, our review of medical reports
of early explorations done when colonial presence was just starting (1885–1905) reveals that syphilis and chancroid
were already present in the nascent colonial trading and administrative posts (frequented by colonial troops, traders
and commercial sex workers), with a few cases in nearby villages; however, in the villages away from posts, reports
mention explicitly that syphilis was absent, and they do not mention chancroid [95,96]. There was evidence of older
syphilis presence (e.g., presence of tertiary syphilis) in the towns of the nation states/kingdoms (e.g., Zande, Foulbe´)
situated near the northern and eastern limits of the equatorial forest block (mainly in savannah or savannah/forest
mosaic areas), spread by Arab, Swahili and Hausa traders [40,93,97,98], and in the Atlantic coast, spread by European
seafarers [40,93].
We believe these observations are credible for several reasons. First, they were made by trained military doctors
who were familiar with STDs and tended to record the observed cases [95,96]. Second, the absence or rarity of
these GUDs in tropical forest can be understood in the light of their epidemiology. Computer simulations show
that syphilis needs a core group of highly promiscuous people to strive [99,100]. Chancroid is even more tightly
linked to commercial sex work than syphilis [100,101]. In precolonial societies of the tropical rainforest, high turnover
commercial sex workers did not exist [102,103], presumably because these societies seldom had social organization
above the level of village or small federations of villages [104]. Thus, we assume that GUDs could not establish stable
footholds in these societies despite continued presence on their coastal and savannah borders.
To the north, in the towns situated in grassland, savannah and savannah-forest mosaic areas, commercial sex
work existed and GUDs were epidemic [40,97,98]. However, in these areas, chimpanzee density was much lower [86,
Gagneux P, Pers. Comm.]. In forest-savannah mosaic areas gorillas are not present [88], and sooty mangabeys exist
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only in the forest galleries [87]. Therefore, the overlap between GUD and human exposure to SIVcpz, SIVgor and
SIVsmm was minimal in precolonial times.
Both T. pallidum and H. ducreyi are at least tens to hundreds of thousands of years old in humans including
in tropical forested Africa [105,106]. However, venereal syphilis (T. pallidum pallidum) is post-Columbian in Africa:
there is phylogenetic and skeletal evidence that it was brought from the New to the Old World in the late 15th
century, by Columbus’ crew [105]. The endemic form of T. pallidum in tropical forest Africa before colonialism is T.
pallidum pertenue (yaws), which does not spread venereally [93,94]. The forms of both T. pallidum pertenue and H.
ducreyi detected in tropical African areas and Pacific Islands, spread mostly and perhaps exclusively by skin-to-skin
contact among children [93,94,106].
Thus, in the areas where human contact with ape and monkey bushmeat is intense, the highly incident GUD
seen after 1885 [40,93,95–97] was, like injections and transfusions, a novel factor.
The biogeography of HIV
Exhaustive collection of fecal samples frommany communities of the relevant primates [1,2,5–7], and phylogeographic
analyses [6,27,29,32], dramatically improved our knowledge of HIV and SIV biogeography. The SIVcpz/HIV-1 phy-
logenetic tree reveals that HIV-1-M likely crossed into humans in southeast Cameroon or nearby areas limited by the
Sangha-Ngoko-Bumba rivers enclosure [1,2]. The further ignition of HIV-1-M happened in Leopoldville/Kinshasa,
and from there the virus spread early on to other cities of Belgian Congo and to neighbouring French Congo and
Angola [27,107].
HIV-1-O and HIV-1-P were acquired from G. gorilla gorilla, but the scarcity of locations from which SIVgor
was retrieved [1,5] does not permit to pinpoint the site of origin accurately. HIV-1-N originated from SIVcpz found
in the Dja river enclosure, south-central Cameroon [2].
HIV-2-A and HIV-2-B are closest to SIVsmm endemic in sooty mangabeys from southwestern Coˆte d’Ivoire [6].
A phylogeographic analysis of HIV-2-A does not exclude the involvement of either Coˆte d’Ivoire or Guinea-Bissau
for initial spread [29], but Coˆte d’Ivoire is more likely considering the SIVsmm phylogenetic evidence [6], together
with the reported extinction of sooty mangabeys from Guinea-Bissau by the 1940s [33].
Connecting biogeography with data on risk factors
This improved biogeographical knowledge allowed us to refocus our investigation of risk factors in time and space.
Sources suggest that in southeast Cameroon, ape hunting was particularly intense [41,108] and SIVcpz prevalence
in wild chimpanzees is about five times the average of P. t. troglodytes [2], implying a particularly high zoonotic
potential in that area.
In addition, we found that, by 1899, GUD was already present in the colonial posts of this region, mainly
brought by soldiers [41,95,96]. By 1911, thousands of mostly foreign soldiers, porters and rowers were working there
for the administration and the main rubber trading company, effectively doubling the number of young men in
the area, thus biasing sex ratio and promoting commercial sex work [41,109]. Injections were practiced in this period,
including atoxyl campaigns against trypanosomiasis and smallpox vaccinations since 1907 [41]. Thus, opportunities
for transmission, either parenteral or sexual, existed.
We also documented that the exports from this area were almost exclusively by river directed to either Leopoldville
or Brazzaville, and the traffic of ivory and rubber was particularly intense in the period 1899–1923 [41]. A zoonotic
HIV-1 strain crossing to humans in southeast Cameroon during this period had the opportunity to migrate to an
urban settlement where circumstances existed allowing further spread/adaptation by serial transmission.
Male circumcision is known to provide partial protection from HIV infection to men and shows a strong
geographical correlation with HIV-1 prevalence [110]. We made an attempt to correlate HIV biogeography with
male circumcision distribution, using an ethnographic approach to obtain information per ethnic group about
male circumcision in early 20th century [40,43]. Among the six main Central African cities that could receive
SIVcpz-infected migrants, three (including Brazzaville) had >90% male circumcision frequency, two (including
Leopoldville/Kinshasa) had it in the range 70–90%, and for one data were lacking. The lower male circumcision
frequency of Leopoldville might have contributed to the emergence HIV-1-M in this town, but the data are too
scarce for a formal analysis [40]. The sensitivity analysis of our GUDmodel showed that GUD prevalence explained
the data better than male circumcision, with differences in male circumcision frequency not being crucial, but this
did not take into account the interdependence of both [40,43]. Indeed, similar as for HIV, GUD acquisition by
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men is inhibited by male circumcision [40,43], and so a lower circumcision rate could have helped HIV to emerge
through its effects on GUD.
For HIV-2, the situation is the reverse, sufficient data exist to evaluate the impact of male circumcision, while
quantitative GUD data at the level of a city is difficult to find. So far, we have tried to obtain GUD data for
the most relevant West African cities during colonial times, as we did for Leopoldville, but we found them only
for Dakar [Sousa, Unpublished Database]. The evidence for lack of male circumcision as a driving factor is
stronger [43]: among 30 cities of West Africa, HIV-2 prevalence in 1985–1991 and male circumcision rates in 1950
were negatively correlated (Spearman rho = -0.546, IQR = -0.553– -0.546, p ≤ 0.0021); while in most cities
male circumcision frequency was, in 1930, >90%, in Guinea-Bissau and Coˆte d’Ivoire it was 40–70%, and these
were the only demonstrably early HIV-2-A epicenters [29,43]; the male circumcision rate in Bissau decreased further
during the independence war (1961–1974) with the presence of Portuguese troops [43].
In addition, in rural southwestern Coˆte d’Ivoire where HIV-2 groups A, B, G, H, I likely originated (based on
the analysis of SIVsmm sequences [6,7]), male circumcision was uncommon in early 20th century, while it was
universal in almost all the remaining sooty mangabey range. We, therefore, suggested that lack of male circumcision
may have helped serial transmission and partial adaptation of HIV-2-A and HIV-2-B in this area [43]. The impact
of lack of male circumcision in this process could have been direct and/or indirect through its effect on GUD
incidence.
Comparison of hypotheses
Transmitted viral diversity & initial adaptation of SIV to humans
During serial transmission of SIV between humans, adaptation could be facilitated by transmitted viral diversity.
Transmission through transfusion results in very high levels of transmitted viral diversity. In approximately 40%
of HIV-1 intravenous transmissions and approximately 20% of sexual transmissions several variants are transmit-
ted [111]. However, sexual transmission of HIV-1 diversity is substantially more common if the exposed person has
genital ulceration [112]. Thus, both GUD and unsafe intravenous injections would allow many transmissions of
multiple diverse viral variants, while transfusions would be the most efficient in this regard.
Risk factors in the early colonial posts
Wild chimpanzee populations collapsed more steeply after approximately 1950, suggesting intensified hunting after
that time (reviewed in [41]). However, several sources indicate intense chimpanzee hunting also in the early 20th
century [41,108,109].
The colonial posts established in the inner forest (1885–1910), although no larger than villages, had a radically
different social life, with a biased sex ratio and sexual promiscuity. There, GUD spread rapidly [93,95]. Some
posts (but not all) had one doctor and/or one or two nurses [93]. For this early period and for interior posts, we
often know the approximate timing of the first injection campaigns (broadly speaking, smallpox vaccinations after
approximately 1890, atoxyl against trypanosomiais after approximately 1905, neoarsenobenzol against syphilis and
yaws after approximately 1911–1920), and of the earliest reports of GUD. As we reviewed above, the standards of
needle hygiene in these posts were probably low.
However, the reports seldom quantify GUD or injections in the posts, in this period [41,93,95–97,109]. In addition,
both GUD and injections were highly correlated, not only on a microspatial level (e.g., present in the posts
themselves, absent in nearby villages [95,96]), but also on a social level (e.g., Africans working directly for the colonial
administration were both more likely to be GUD-infected and treated by injections [93]). Because of this, if SIV
was transmitted between humans in these posts, GUD and injection intensity were correlated, and may have acted
in concert to allow additional spread of HIV.
Risk factors in the cities
For the cities, the available data are far more complete, in several respects. First, there are colonial reports quantifying
the annual number of GUD cases (and even the proportion of syphilis cases that are primosecondary, and hence
associated with genital ulcers), and of diseases treated by injections [40,61,68] [Sousa, Unpublished Database].
Second, demographic data detailing the city population, partitioned by gender and adults/children and sometimes
by ethnic group, are available [40,43]. Third, urban dwellers were tightly controlled and health facilities were well
staffed, making underreporting or misdiagnosing of disease a lesser problem. This allowed us to infer more reliable
incidence rates for GUDs in Leopoldville (1911–1958) [40]. We found that primosecondary syphilis, chancroid
future science group 10.2217/fvl-2017-0042
Perspective Sousa, Mu¨ller & Vandamme
Congo (TP)
Congo (SV)
Cameroon (TP)
Cameroon (SV)
Ivory coast (TP)
Ivory coast (SV)
20
320
80
1280
5120
1920 1925 1930 1935 1940 1945 19551950
Thousands
Figure 2. Progression of healthcare in Central and West Africa. The progression of the number of treated patients
(excluding vaccinations) for any condition (TP) and the number of smallpox vaccinations in the three African colonies
more relevant to HIV-1 and HIV-2 origins. Based on colonial reports (Sousa, Unpublished Database).
and lymphogranuloma venereum peaked in this city in 1910–1935 and then their incidence rates declined by
two orders of magnitude until the late 1950s [40]. After we published this study, we gathered data for other cities,
albeit not as complete as for Leopoldville, and the pattern is broadly similar [sousa, unpublished database]. Peak
GUD time roughly coincided with the tMRCAs of all main HIV groups [40,24–30], consistent with a critical role for
GUD-enhanced heterosexual transmission.
These timings of GUD incidence are explained by healthcare patterns. Leopoldville grew fast in the period
1918–1929, with many men being recruited to work in infrastructure construction, which generated a 3:1–4:1 sex
ratio and favored sex work, at a time of incipient healthcare [40]. Only in the period 1929–1935, after the Croix
Rouge STD clinic opened, did mass screening permit to treat nearly all syphilis-infected people in Leopoldville
with neoarsenobenzol and bismuthics. Effective treatment against chancroid and lymphogranuloma venereum
came only in the late 1930s with sulfonamides, and then improved after 1947 with antibiotics [40,61,81].
City growth was essentially exponential throughout the entire 20th century [40]. Injections also increased expo-
nentially, as the health system reached more patients, and expanded in resources and variety of treatments [35,40,41].
Overall, the number of treated patients was two orders of magnitude higher in the late 1950s than in the 1920s
(Figure 2).
Organized transfusion services and programs were established in the 1950s in most colonies and the number
of transfusions increased in the following decades. Only sporadic reports of transfusions exist for the 1920s and
1930s [39]. Needle and syringe sterilization standards deteriorated after approximately 1960, when independence
caused most qualified health personnel to leave these countries [35]. Therefore, parenteral risks were much higher
shortly after colonial independence compared with early 20th century.
Parenteral risks were not peaking at the timing of tMRCAs of all epidemic HIV groups, they continued to rise for
at least another half century. Thus, if injections were a critical factor, one would expect many more epidemic HIV
groups starting after mid 20th century than in early 20th century. HIV-1-N originated in mid 20th century [31],
and the same may apply to HIV-1-P [4], but they are rare (together <20 cases found) and not well adapted [1,4]
(i.e., they are not Stage 5 infections). No other epidemic HIV groups were identified after massive efforts of
screening tens of thousands of HIV seropositive samples from Cameroon with peptides of all HIV-1 groups and
many SIVs [4,14,15,113]. Therefore, we propose that short parenteral serial transmission events, parenteral outbreaks
and other forms of parenteral hypotheses, even if contributing to partial HIV adaptation, and even if necessary
to give rise to epidemic HIV, are unlikely to be sufficient to promote the level and kind of adaptation needed to
become a self-sustaining Stage 5 human sexually transmitted pathogen.
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Figure 3. A three-step model for HIV adaptation and emergence.
The three panels illustrate our proposed three steps in HIV adaptation and emergence. In Step 1, there is a
simian-to-human transfer of SIV genetically suitable to adapt to humans. In Step 2, we outline several alternative (not
mutually exclusive) processes potentially generating rough HIV adaptation. In Step 3, enhanced heterosexual
transmission involving GUD produces a Stage 5 capable HIV strain.
GUD: Genital ulcer disease; SIV: Simian immunodeficiency virus.
A three-step model for HIV adaptation & emergence
In Table 1, we list the factors potentially contributing to SIV adaptation to become HIV, and arguments over
the possible sufficiency of each factor to allow HIV to reach full adaptation (i.e., the level and kind of adaptation
necessary to reach Stage 5 as an STI). As the Table shows, if any of the factors 1–4, or any combination of them
were sufficient, HIV epidemics would have emerged continuously over millennia, much like in the case of HTLV.
If any of the parenteral factors (5–8), or any combination of one of them with factors 1–4 were sufficient, we
should observe many more Stage 5 HIVs emerging from mid 20th century onward. To explain the time paradox of
epidemic HIV emergence and be fully compatible with all observations, there is no other existing hypothesis than
one that includes GUD. In absence of other evidence, the most plausible explanation for full adaptation would
have to include long chains of sexual transmission involving GUD (factor 11), whether or not in combination with
some of the parenteral or other factors.
Based on the arguments expressed so far, the phylogenetic patterns of SIV and HIV, the existing evidence
about factors potentiating adaptation and the co-factor effects on HIV transmissibility, we propose the following
three-step model for HIV adaptation and Stage 5 emergence (illustrated in Figure 3).
Step 1
There was a simian-to-human transfer of a SIV that had higher genetic potential to adapt to humans. There is
evidence that such selection happened, at least for HIV-1-M: SIVcpz of P. t. troglodytes is fewer mutational steps
away from both evolving a human-adapted amino acid in the Gag30 site (enabling human tetherin antagonism)
than SIVcpz of P. t. schweinfurthii. In addition, SIVcpz from southeast Cameroon sites requires fewer mutational
steps for this adaptation than SIVcpz from most other Cameroonian locations [3]. We hypothesize that similar
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Table 1. Factors potentially contributing to HIV adaptation.
Factors potentially contributing to biological
adaptation of SIV to humans
Estimated temporal pattern of
factor
Prediction for temporal
distribution of epidemic HIV
origins if the factor alonewas
sufficient to Stage 5 transition
Other arguments Consistent
with
evidence
Present in precolonial era (before 1885)
1. SIV preadaptation
Some SIVs are more preadapted to human infection
than others, e.g., within SIVcpz, the ancestors of
HIV-1-M are more preadapted than other strains [1,3]
Pattern not expected to differ
since millennia
Multiple emergences during
millennia
No
2. Individual host genetic factors Pattern not expected to differ
since millennia
Depending on frequency of the
specific host genetic factor,
potential emergence stable
during millennia
No
3. Viral diversity transmitted
Experiments suggest it can be relevant [47–49]
Relatively common during
exposure to bushmeat; likely
repeatedly during millennia
Multiple emergences during
millennia
No
4. Serial sexual transmission in absence of GUD
Serial passage experiments suggest it can be
relevant [35,59]
Pattern not expected to differ
since millennia
Emergence during millennia
with a frequency depending on
the likelihood of short chains of
transmission
Simulations show that
even short chains are rare
without GUD [40]
No
Combinations of factors 1–4
e.g., 1 + 2, 1 + 2 + 3, 1 + 2 + 4, etc.
Pattern not expected to differ
since millennia
Depending on the likelihoodof
the required combination of
factors, occasional emergence
during millennia
It cannot be excluded that
occasional short-lived HIV
epidemics might have
taken place in the past
Unlikely
Present in colonial and postcolonial era (after 1885)
5. Serial transmission through unsafe injections
Serial passage experiments suggest it can be
relevant [35,59]
Injections 2 orders of
magnitude more common in
late 1950s than in 1920s;
sterilization standards worse
after ∼1960
Many more Stage 5 emergences
starting in mid 20th century
than in early 20th century – the
opposite is observed
Unlikely
6. Serial transmission through transfusions
Serial passage experiments suggest it can be
relevant [35,59]
Transfusions rare before 1950 Same as in 5 Tranfusions allow maximal
viral diversity transmitted
Unlikely
7. Parenteral outbreak generating dozens of
infections (e.g., in hospital or clinic)
Multiplication of infections could favor adaptation
Hospital entries: in late 1950s,
Ten-times higher than in 1930,
50-times higher than in 1915;
amount of injections in
hospitals probably proportional
to hospital entries
Same as in 5 Unlikely
8. Massive parenteral transmission Same as in 5 Same as in 5 Injection intensity of rural
campaigns much lower
than in IVDUs [41]
Unlikely
Combinations of factors 1–8
e.g., 1 + 5, 1 + 3 + 5, 1 + 3 + 6, etc.
Far more common after 1950 Same as in 5 Unlikely
9. Sexual serial transmission enhanced by GUD
Serial passage experiments suggest it can be
relevant [35,59]
GUD almost absent before
1885; far more common in
colonial cities in the period
1900–1935; 2 orders of
magnitude less common in late
1950s
More Stage 5 emergences
starting in early 20th century,
as is observed
These chains may have
been common and HIVs
are rare
Less likely
10. Long chain of sexual transmission, enhanced by
sex work, with GUD rare
More brothels and high
turnover sex workers after
1960 [38]
Same as in 5 Simulations suggest sex
work less important than
GUD [40]
Less likely
11. Long chain of sexual transmission, enhanced by
GUD
Same as in 9 Same as in 9 Simulations show this is
possible even with
ill-adapted HIV [40]
Yes
Combinations including 11
e.g., 1 + 2 + 10 + 11, 1 +3 + 5 + 11, 1 + 3 + 6 + 11, 1
+ 3 + 9 + 10 + 11, etc.
Peak in 1910–1935 if GUD was
the crucial factor
Same as in 9 Several factors other than
GUD (e.g., factor 1
probably played a
role [1,3])
Yes
In the leftmost column, we list the factors/combinations of factors that could have contributed to SIV/HIV adaptation to the human host, with references supporting a possible role
in adaptation. In the second column, we list their temporal patterns. In the third column we list what would be the temporal pattern of Stage 5 HIV emergences observed if that
factor/combination alone was sufficient to let HIV transition to Stage 5. In the fourth column we add other relevant arguments. The rightmost column contains our evaluation of the
plausibility of each factor/combination alone having been sufficient for epidemic emergence and thus being consistent with the observed pattern of origins of the four Stage 5 HIVs.
GUD: Genital ulcer disease; IVDU: Intravenous drug user; SIV: Simian immunodeficiency virus.
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intersubspecies and interregional genetic differences in SIV suitability to human adaptation might have played a
role in the origin of the other HIV groups as well.
Step 2
After crossover, the virus may have partially adapted to the human host, helped by a high transmitted viral
diversity (e.g., due to a large inoculum or multiple bushmeat exposures), the plausibility of which is suggested by
experiments [47–49]. Another factor that may cause partial adaptation is a possible short chain of serial transmission
between acutely infected people [35,36,59]. This could have been sexual, parenteral or mixed (Figure 3). A sudden
parenteral outbreak fueled by parenteral risk factors concentrated in time and space may also help adaptation, by
multiplying the number of hosts in which SIV can ‘explore’ favorable mutations. We do not know which of these
factors operated for each HIV group, and so we take the pluralistic view that any combination of such factors may
be sufficient for the partial adaptation (Figure 3, center). However, whatever the mechanism, we believe this step
only generated partial adaptation, not capable of Stage 5 emergence, based on the timing arguments we presented
so far (summarized in Table 1). In its current state, HIV-1-N could be an example of such a Stage 3 or Stage 4
pathogen.
Step 3
After partial adaptation, a long chain of enhanced heterosexual transmission with GUD involvement allowed the
strain to gradually fine-tune its adaptation until attaining Stage 5 as an STI. We consider this a necessary step for
full adaptation, because of the timing arguments we discussed: highly incident GUD was the only risk factor that
peaked in early 20th century colonial cities and then faded away, and because all four epidemic HIV groups are
primarily STIs, and not mainly parenterally transmitted viruses like HCV. Although parenteral passages might have
been important initially to imbue the virus with a general adaptation to host target cells and restriction factors,
enhanced sexual transmission was likely necessary to allow for sexual passages, which would allow the virus to
better adapt to be transmitted by this route. We believe a long chain, of dozens, perhaps up to a couple of hundreds
of transmissions was necessary because: if just a few were sufficient, then this step would be essentially similar to
the short-chain serial transmission scenarios, and such events had ample opportunities to happen by the parenteral
route, after mid-20th century, and no well-adapted HIV resulted (Table 1); a long chain is a larger scale event, thus
less common than short chains, which is consistent with the scarcity of Stage 5 HIVs. The presence of GUDmakes
it more likely that various diverse viral variants are transmitted [112] (illustrated in Figure 3, right). Our simulations
showed that such long chains are possible even with an ill-adapted HIV, and that GUD is the most crucial factor
for them to happen [40].
Non-GUD STIs such as those causing urethritis and vaginal discharge might have also played a role, because
although they are associated with a lower co-factor effect on HIV transmission [79,114], they were more prevalent
than GUDs and their peak coincided with the peak of GUD [Sousa, unpublished database].
Discussion & open points
The timing of the origin of epidemic HIVs, in comparison with other viruses, implies that novel enabling factors
were involved starting in late 19th–early-20th century. Large population agglomerations and use of firearms were
not novel in the rainforest [57,58]. However, the social changes associated with colonial cities were novel, and they
played a role by promoting commercial sex work and GUD. Intense GUD existed in towns situated in savannah
areas before 1885 [97,98], but human contact with chimpanzees and sooty mangabeys was far lower there. Thus,
highly incident GUD was a novel factor in the most relevant habitats.
Injections and transfusions were also novel factors. There are only sporadic reports of transfusions in the
1920s [38,39,42]. However, additional archival research may reveal transfusions that were not discussed in the
published literature, and so the transfusion hypothesis of adaptation (a variant of the Parenteral Serial Transmission
Hypothesis) remains worth considering. Parenteral transmission has been documented in modern IVDUs and
hospital outbreaks [41,60], however, the average injection intensity in early-20th century African communities
was far below the levels seen in modern parenteral outbreaks, lower than currently required for HIV-1 to have
R0 >1. Yet certain subsets of hospital/clinic patients received many injections, which leads to the parenteral
outbreak hypothesis, whereby the virus spread parenterally to dozens of patients, enhancing its chances of acquiring
favorable mutations. However, this hypothesis depends crucially on: the still ill-adapted virus having landed in
patient communities where injection frequency was high; substantial levels of nonsterilization of needles. In early-
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20th century, high frequency of injections per patient existed in Leopoldville, in the 1920s, in the trypanosomiasis
lazaret [66,68], in the main hospital, and in the Croix Rouge STD clinic from 1929 onward [38,61,81], with sterilization
standards probably being lower in the latter [38].
Under this scenario, the four epidemic groups of HIV would require four such events: one in either southeast
Cameroon or Leopoldville/Kinshasa, to explain HIV-1-M, another in Cameroon to explain HIV-1-O, and two
others in Coˆte d’Ivoire to explain HIV-1-A and HIV-1-B, all in a two decade’s period, and no such events in
mid-20th century, when hospital populations were much larger, and many more injections and transfusions were
administered. The concentration of the emergence of four HIV groups in a short time window would be left
unexplained (Table 1).
In contrast, in the frame of the enhanced heterosexual transmission hypothesis, the temporal coincidence between
the emergences of the four groups of HIV is an integral part of the hypothesis, and mirrors the temporal coincidence
of high intensity of sexual transmission co-factors in most colonial cities. There was a rush to build infrastructure,
producing organized hiring of male workers, and thus a male-biased sex ratio, which promoted commercial sex
workers and milder forms of sexual promiscuity (e.g., the so-called femmes libres) [38,40,85]. This situation ignited
GUD epidemics, at a time whenmass treatments were not yet available. The latter came only in the early 1930s and,
for chancroid and lymphogranuloma venereum, they could only be effective with the introduction of sulfonamides
in the late 1930s [40]. In addition, this was a time of lower male circumcision frequency in many Central and West
African cities, including Leopoldville and Abidjan [40,43].
We did not investigate the role of traditional practices among Central African women that involve the use of
herbal agents in the vagina to enhance sexual experience. This practice produces genital irritation and inflammation,
and has been hypothesized to contribute to HIV spread [115,116]. It is unclear whether this contributes significantly
to the HIV epidemic [116]. Since the practice is likely old, it could have increased the odds of HIV emergence before
GUD became epidemic. Further studies are needed to determine the frequency and duration of such inflammation,
and their impact on HIV per act transmissibility.
HIV-1-N and HIV-1-P, probably arose in mid-20th century [4,31]. Their rarity and the apparent lack
of other groups starting from that epoch, after a two-decade-long massive screening effort performed in
Cameroon [4,14,15,113], argue that few HIV strains emerged in that time frame. Even if new ones are still to
be discovered, they are not expected to be better adapted than these two rare groups, or else we should have been
able to detect them already. This absence of Stage 5 well-adapted strains emerging after approximately 1950 is not
easy to explain if we assume that parenteral risks were the critical factors, because injections and transfusions were
far more common at that time than they had been 2–3 decades earlier ([35,39,41]; Figure 2 &Table 1). Even assuming
that needle sterilization standards were worse in early compared with mid-20th century, there was a worsening of
standards again after approximately 1960 [35]. Also, cities were much larger, and growing exponentially, implying
more rural immigrant arrivals per unit of time.
This suggests that parenteral risks alone were not a sufficient factor (Table 1), although they could have
been necessary and complemented by another factor. The best candidate for that additional factor is enhanced
heterosexual transmission in cities with high GUD incidence. The absence of well-adapted HIV emergence after
the mid-20th century is consistent with the steep decline of bacterial GUDs [40], still low levels of HSV-2 [92] and
high male circumcision frequency (>90%) [40,43].
Therefore, the Parenteral Serial Transmission and/or the parenteral outbreak hypotheses on their own are not
able to explain the emergence of epidemic HIVs. We proposed a three-step model instead, by which these factors
may still have been necessary, but had to be complemented by enhanced heterosexual transmission (see last section
and Figure 3).
In recent decades, HSV-2 became an important cause of genital ulcers in Africa [89,92]. The enhanced heterosexual
transmission hypothesis would predict this situation to spark new HIV epidemic groups, but no epidemic HIV
group appears to be dated from that time frame, generating a difficulty for the hypothesis. We can think of
two reasons for this. First, HSV-2 causes short chronic ulcer duration (<1 week) and this may not favor serial
transmission because an individual acquiring ill-adapted SIV/HIV through an HSV-2 ulcer will have his/her ulcer
healed before HIV achieves high viral load, and will thus not transmit further. Here a cautious note is needed:
there is evidence that HSV-2 infection causes continued genital inflammation past the healing of ulcers, potentially
affecting HIV transmissibility and susceptibility for longer than the duration of recurrent ulcers [117]. However, if
we accept that the effect of HSV-2 on HIV transmissibility and susceptibility is mainly when ulcers are active, as
has been proposed by several modeling studies [79,114], our argument above holds.
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Second, the high prevalence of HIV-1-M in core transmitters seen after approximately 1990 may thwart new
HIV emergence by partial inhibition of superinfection [118] or elimination of core transmitters through AIDS.
Alternatively, there may not have been sufficient time for such an HIV to have spread enough to be detected.
Further research will be needed to understand the relative contributions of sexual and parenteral transmission
to the origin and early spread of HIV. Another interesting research question is to understand whether, after
transmission to the first human, each HIV group was initially transmitted in the nearby forest posts or whether it
was brought directly to a city by the index case.
Understanding the factors that permitted HIV groups to emerge may be important to prevent new SIVs to
take hold in the human population, and it may provide a template to understand the zoonotic origins of other
major human infectious diseases [13]. A high spatial and temporal concentration of co-factors of transmission may,
for example, be important also to evaluate whether Ebola outbreaks could spark a pandemic. Some outstanding
questions and prospects for future research are summarized in section Future perspective.
In conclusion, both the parenteral and the sexual hypotheses provide plausible explanations for the initial
adaptation of HIV groups. Further adaptation and spread by enhanced heterosexual transmission was probably
necessary (Figure 3). The enhanced heterosexual transmission hypothesis proposes a major role for a combination
of the co-factors of heterosexual transmission (GUDs, STDs, commercial sex work and lack of male circumcision).
Such factors likely allowed the adaptation of HIV to become a human STI, rather than a mainly parenterally
transmitted pathogen like HCV. The timing of peak GUD and relatively low male circumcision in cities fits the
tMRCAs better than other proposed enabling factors (Table 1). By emphasizing heterosexual transmission, which
currently overwhelmingly dominates the HIV epidemic [44,45], without the need to invoke additional factors, this
hypothesis thus fulfills the principle of parsimony [40,41]. In any case, the emergence of HIV needed novel enabling
factors, and all the credible ones we reviewed were associated with societal changes during early colonial rule.
Future perspective
To tackle the unsolved questions we outlined here, further virological research can be done.
 New phylogeographic studies may reveal the early epicenters of HIV-1-O and HIV-2-B, and remove the
uncertainty about the HIV-2-A epicenter [29]. This is going to require more viral sequences from diverse
locations;
 Further detection and sequencing of ‘fossil’ HIV strains from old sera and/or biopsy samples, similar to studies
already done [26] may permit to narrow down the uncertainty boundaries of the tMRCAs. Several such projects
are ongoing;
 Better recombination analyses of early strains may help to understand whether recombination, either between
two bushmeat-acquired SIVs in the same human, or between strains already infecting several humans played a
role in the initial adaptation of each HIV group;
 Screening more samples from humans exposed to bushmeat (expanding on [7,14,15]), using peptides from all
HIVs and many SIVs will likely detect new zoonotic human SIV/HIV infections. In most infections detected
by serology, virus retrieval is unlikely [14,15]. However, if virus is retrieved in some cases (arguably this is the
situation of some rare HIV-2 groups [6,7]), it could help us understand how the epidemic groups originated
(e.g., whether the virus can sometimes remain infectious beyond acute infection even without adaptation by
serial transmission);
 More extensive sampling and sequencing of SIVcpz, SIVgor and SIVsmm from wild primates may
pinpoint the geographical origin of each HIV group more precisely. Research might be confounded
by ape and monkey movements during the last century, and by the shrinking of the simian pop-
ulations due to human activity; some of the relevant SIV lineages might have disappeared entirely;
In addition, additional research in nonvirological fields can be combined fruitfully with the evidence gath-
ered in the projects above, as follows.
 New archival, colonial historical and anthropological research could be done about bushmeat practices, sexual
and parenteral risk factors, demography and transportation networks. Several studies have already followed these
paths [27,34–43,71,81], and future advancements in virological knowledge (points 1–5) could further refine the
temporal and spatial focus of such analyses, improving their effectiveness;
future science group 10.2217/fvl-2017-0042
Perspective Sousa, Mu¨ller & Vandamme
 The data about risk factors might be used in epidemiological simulations (extending on [40]), modeling both
sexual and parenteral transmission and, thus, estimating the relative contributions of either forms of transmission
to HIV adaptation and initial spread;
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Evidence for HIV adaptation & novel enabling factors
 All four main epidemic HIV groups’ origins are dated to the late 19th–early-20th century, contrasting with the
antiquity of human T-cell lymphotropic viruses and other viruses.
 Simian immunodeficiency virus (SIV) antibodies are present in 8–17% of HIV-negative Central Africans who hunt
or butcher bushmeat, without giving rise to new strains of HIV.
 SIV is estimated to be at least 77,000 years old, and hunting and butchering of SIV-carrying primates has been
common practice throughout human history.
 Therefore, there were ample opportunities for SIV to cross to humans during millenia.
 This suggests that HIV emergence was enabled by novel factors allowing adaptation of SIV to be sexually
transmitted among humans; these factors must have arrived to the habitats of chimpanzees, gorillas and sooty
mangabeys after late 19th century.
Proposed novel enabling factors (post late 19th century)
 Large population agglomerations and firearms were not novel in inner Central Africa.
 Unsterile injections or transfusions were novel, and could have helped SIV to adapt to humans by parenteral
serial transmission.
 We proposed as critical factor enhanced heterosexual transmission by spatial and temporal concentration of
commercial sex work, genital ulcer disease (GUD) and lack of male circumcision.
 We demonstrate that highly incident GUD was a novel factor in the rainforest, starting with the establishment of
colonial posts.
Review of the evidence relevant to evaluate the different hypotheses
 Unsterile injections, GUD and transfusions all had the potential to facilitate SIV adaptation to humans.
 In colonial cities, GUDs were highly incident in the early-20th century, and then dramatically declined with mass
treatments. Their peak in cities coincided with lower male circumcision frequency, and with the origin of the
epidemic HIV strains.
 Our previous model showed the plausibility of GUD-associated serial transmission of ill-adapted HIV-1. We
address criticisms to the model.
 In early-20th century, injection frequency was high only for smaller groups of patients. Transfusions became
widespread only after approximately 1950.
 Parenteral risks increased exponentially, following development of healthcare systems, peaking after 1950.
Sterilization standards worsened after independence of the colonies before getting better in the last two
decades.
 Strong evidence indicates the dominant role of parenteral transmission for HCV, and this transmission route
might have been crucial also for its emergence. However, in contrast to HCV, HIV is mainly an STI, with much
lower parenteral transmission risk, and the findings on HCV cannot be automatically extrapolated to HIV.
Conclusion
 Early-20th century injection campaigns are unlikely to have spread HIV massively, to a degree seen in modern
intravenous drug users, but could have facilitated early serial transmission events.
 The fact that the HIV groups starting after 1950 did not spark epidemics, when injections, transfusions,
rural-urban migration and bushmeat intensity peaked, suggests that parenteral serial transmission, even if
necessary, was not sufficient for epidemic emergence.
 Enhanced heterosexual transmission fits not just the start, but also the end of the time window of HIV epidemic
origins, because after 1950 GUD was subdued and male circumcision was almost universal in most relevant cities.
 We thus propose that enhanced heterosexual transmission was the main driver of HIV adaptation and
emergence, even if parenteral serial transmission also contributed to the initial steps of adaptation. We propose
a three-step model for HIV adaptation: an initial crossover of genetically preadapted SIV, followed by small scale
events generating partial adaptation, and then long chains of heterosexual transmission allowing full adaptation
to be a Stage 5 STI.
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